Keynote Presenter

Tina Lockwood, PhD, DABCC, DABMGG

Division Head, Genetics & Solid Tumors at UW Medicine

Dr. Lockwood is a Professor and Division Head of Genetics in the Department of Laboratory Medicine and Pathology at the University of Washington School of Medicine. She serves as Director of the Genetics and Solid Tumors Laboratory and Clinical Director of the Northwest Genomics Center. Her interests include the development and application of molecular methods for the detection of genomic alterations in genetic disease, hematologic malignancies, and solid tumors. Dr. Lockwood has also been active in the design and implementation of educational resources related to training in genomic medicine. She is currently involved in several research studies, including several cell-free DNA grants, the Seattle Flu Study, and the NIH AllofUs program. She is also active in working groups within the Association of Molecular Pathology (AMP), the American Society of Clinical Oncology (ASCO), and the College of American Pathology (CAP).

Nafiseh Jafari, PhD

Chief Science Officer at nRichDX

Dr. Jafari joined nRichDX in January 2020 and has over 10 years experience in life science research. She is a scientific leader with a passion for building and managing high performance teams. Dr. Jafari has managed multimillion dollar development projects leading to the successful creation and launch of multiple products. Immediately prior to joining nRichDX, She was a Project Manager leading cross-functional teams at Abbott Diagnostics. Dr. Jafari holds a B.S. degree in Chemistry from Sharif University of Technology and earned her Ph.D. degree in Biochemistry and Molecular Biology at Western Michigan University.

Dr. Jafari will provide a brief overview of the Revolution Sample Prep System^® for extraction of key liquid biopsy analytes, including cfDNA, cfRNA, cf-Total Nucleic Acid, and CTCs, from biofluids.